India`s pharma exports rise to $14.57 billion in April-October of FY23: Udaya Bhaskar
![](https://portfolio.investmentguruindia.com/investmentguruimages/upload/post/2022/11/dd7b4f54f20bcf823e5bcb47cba849fe.jpg)
Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel
https://t.me/InvestmentGuruIndiacom
Download Telegram App before Joining the Channel
Director General of Pharmaceuticals Export Promotion Council of India (Pharmexcil) -- Udaya Bhaskar has said pharmaceutical exports from India registered a growth of 4.22 percent to reach $14.57 billion during the April-October period of current finical year (FY23) despite a negative trend last month.
In October, exports fell by 5.45 per cent to $1.95 billion. He said strengthening of dollar against the currencies of some of the key countries has also resulted in decline in exports during October besides the sanctions resulting from the Russia-Ukraine war. Further, Bhaskar said he is hopeful of ending the current fiscal at around $27 billion as against $24.62 billion during the last financial year.
Besides, he said ‘Our exports in the category of vaccines are in a very bad shape. Despite the above and Russia-Ukraine war factors, we are on a positive side.’ India's overall exports contracted by 16.65 per cent to $29.78 billion in October 2022 as compared to the last year's period, according to data released by the Ministry of Commerce recently. During April-October 2022, exports recorded a growth of 12.55 per cent to $263.35 billion.
![](https://portfolio.investmentguruindia.com/uploads/news/jul04v89_Wex0B3E.jpg)
![](https://portfolio.investmentguruindia.com/uploads/news/religare broking.jpg)
![](https://portfolio.investmentguruindia.com/uploads/news/HDFC Ltd.jpg)
![](https://portfolio.investmentguruindia.com/uploads/news/Zomato07.jpg)
![](https://portfolio.investmentguruindia.com/uploads/news/Axis Securities Ltd.jpg)
![](https://portfolio.investmentguruindia.com/uploads/news/Piyush Goyal07.jpg)
![](https://portfolio.investmentguruindia.com/uploads/news/jul04v38_zDiylqc.jpg)
![](https://portfolio.investmentguruindia.com/uploads/news/Prashant Thakur ANAROCK Group.jpg)
![](https://portfolio.investmentguruindia.com/uploads/news/jul03v152_BhgJWbe.jpg)
![](https://portfolio.investmentguruindia.com/uploads/news/Shrikant Chouhan.jpg)
Top News
![](https://portfolio.investmentguruindia.com/investmentguruimages/upload/post/2023/04/ef771b18314451bf22b9260519a76812.jpg)
India remains globally attractive destination for investment due to structural reforms: FM N...
Tag News
![](https://portfolio.investmentguruindia.com/investmentguruimages/upload/post/2023/09/c5541407585e9dfdc52f905c92d59e61.jpg)
Monthly Debt Market Update, September 2023: CareEdge Ratings
![Quote on RBI decision to discontinue the incremental cash reserve ratio (CRR) By Dr. Manoranjan Sharma, Infomerics Ratings](https://portfolio.investmentguruindia.com/investmentguruimages/upload/post/2023/09/3fb5395769079c26d9056714d034c581.jpg)
![Governance mechanism, customer-centricity can help in fintech ecosystem sustainable growth: Ajay Chaudhary](https://portfolio.investmentguruindia.com/investmentguruimages/upload/post/2023/09/07e25a74a16d5c092d179215565d0295.jpg)
![3 Centres of Excellence set up by TIDCO finding good traction: Tamil Nadu Minister](https://portfolio.investmentguruindia.com/investmentguruimages/upload/post/2023/09/e6ff15c8d3a72074f69cb881ab6584e7.jpg)